Search research articles
Contact Us
Filters
Showing results (121-130 of 201) with videos related to
Page
of 21
Sort By:
Gynecologic Oncology
|
April 25, 2013
Implementation of tumor testing for lynch syndrome in endometrial cancers at a large academic medical center
Jessica Moline, Haider Mahdi, Bin Yang, et al.
Gynecologic Oncology Reports
|
November 11, 2021
Efficacy of hyperthermic intraperitoneal chemotherapy and interval debulking surgery in women with advanced uterine serous carcinoma
Laura M Chambers, Danielle Chau, Meng Yao, et al.
Gynecologic Oncology
|
October 5, 2021
Development and validation of a comprehensive clinical risk-scoring model for prediction of overall survival in patients with endometrioid endometrial carcinoma
Mariam M AlHilli, Lisa Rybicki, Caitlin Carr, et al.
Gynecologic Oncology
|
November 29, 2011
Endometrial stromal sarcoma: analysis of recurrence following adjuvant treatment
Tiffany L Beck, Pankaj K Singhal, Hugh M Ehrenberg, et al.
Anti-Cancer Drugs
|
September 14, 2021
PARP inhibitors decrease response to subsequent platinum-based chemotherapy in patients with BRCA mutated ovarian cancer
Peter G Rose, Meng Yao, Laura M Chambers, et al.
Acta Cytologica
|
April 29, 2011
Abnormal cervical cytology in the diagnosis of uterine papillary serous carcinoma: earlier detection of a poor prognostic cancer subtype?
Malgorzata E Skaznik-Wikiel, Stefanie M Ueda, Heidi E Frasure, et al.
Journal of Minimally Invasive Gynecology
|
November 23, 2020
Fertility-Sparing Surgery for Early-Stage Cervical Cancer: A Systematic Review of the Literature
Michelle L Kuznicki, Laura M Chambers, Molly Morton, et al.
Gynecologic Oncology
|
July 15, 2015
A phase II trial of trebananib (AMG 386; IND#111071), a selective angiopoietin 1/2 neutralizing peptibody, in patients with persistent/recurrent carcinoma of the endometrium: An NRG/Gynecologic Oncology Group trial
Kathleen N Moore, Michael W Sill, Meaghan E Tenney, et al.
The New England Journal of Medicine
|
December 14, 2004
Secondary surgical cytoreduction for advanced ovarian carcinoma
Peter G Rose, Stacy Nerenstone, Mark F Brady, et al.
Gynecologic Oncology
|
September 20, 2020
Impact of antibiotic treatment during platinum chemotherapy on survival and recurrence in women with advanced epithelial ovarian cancer
Laura M Chambers, Michelle Kuznicki, Meng Yao, et al.
Page
of 21
Search research articles
Search
Showing results (121-130 of 201) with videos related to
Sort By:
Page
of 21
Gynecologic Oncology
|
April 25, 2013
Implementation of tumor testing for lynch syndrome in endometrial cancers at a large academic medical center
Jessica Moline, Haider Mahdi, Bin Yang, et al.
Gynecologic Oncology Reports
|
November 11, 2021
Efficacy of hyperthermic intraperitoneal chemotherapy and interval debulking surgery in women with advanced uterine serous carcinoma
Laura M Chambers, Danielle Chau, Meng Yao, et al.
Gynecologic Oncology
|
October 5, 2021
Development and validation of a comprehensive clinical risk-scoring model for prediction of overall survival in patients with endometrioid endometrial carcinoma
Mariam M AlHilli, Lisa Rybicki, Caitlin Carr, et al.
Gynecologic Oncology
|
November 29, 2011
Endometrial stromal sarcoma: analysis of recurrence following adjuvant treatment
Tiffany L Beck, Pankaj K Singhal, Hugh M Ehrenberg, et al.
Anti-Cancer Drugs
|
September 14, 2021
PARP inhibitors decrease response to subsequent platinum-based chemotherapy in patients with BRCA mutated ovarian cancer
Peter G Rose, Meng Yao, Laura M Chambers, et al.
Acta Cytologica
|
April 29, 2011
Abnormal cervical cytology in the diagnosis of uterine papillary serous carcinoma: earlier detection of a poor prognostic cancer subtype?
Malgorzata E Skaznik-Wikiel, Stefanie M Ueda, Heidi E Frasure, et al.
Journal of Minimally Invasive Gynecology
|
November 23, 2020
Fertility-Sparing Surgery for Early-Stage Cervical Cancer: A Systematic Review of the Literature
Michelle L Kuznicki, Laura M Chambers, Molly Morton, et al.
Gynecologic Oncology
|
July 15, 2015
A phase II trial of trebananib (AMG 386; IND#111071), a selective angiopoietin 1/2 neutralizing peptibody, in patients with persistent/recurrent carcinoma of the endometrium: An NRG/Gynecologic Oncology Group trial
Kathleen N Moore, Michael W Sill, Meaghan E Tenney, et al.
The New England Journal of Medicine
|
December 14, 2004
Secondary surgical cytoreduction for advanced ovarian carcinoma
Peter G Rose, Stacy Nerenstone, Mark F Brady, et al.
Gynecologic Oncology
|
September 20, 2020
Impact of antibiotic treatment during platinum chemotherapy on survival and recurrence in women with advanced epithelial ovarian cancer
Laura M Chambers, Michelle Kuznicki, Meng Yao, et al.
Page
of 21